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Scholarly Project Introduction 
Hypertension is a chronic disease that has been a major problem in the African American 
community for decades. Although numerous research studies have examined interventions to 
combat this disease, there has been very little research published that focused on African 
Americans with hypertension in a rural setting. Rural residents experience many difficulties in 
accessing healthcare services. This difficult access is a disadvantage that results in higher 
morbidity and mortality rates compared to those of their urban counterparts. Being from a small 
town in Mississippi, I have witnessed first hand the many barriers that are encountered. 
Individuals who live in a rural community may have limited access to healthcare providers. 
Residents may need to travel greater distances for healthcare, and the healthcare facilities in 
these areas are small and oftentimes provide services only during particular hours. The main 
objective of this DNP scholarly project was to evaluate a strategy to motivate African Americans 
in rural communities to improve hypertension control as one step toward improved involvement 
in their personal health.  
This journey began with a synthesis of literature, which focused on reviewing the barriers 
associated with medication non-adherence and interventions used to improve blood pressure 
control.  Once the information was gathered and the gaps were identified, the direction of the 
scholarly project was clear.  After clarifying the purpose of the project, work began to select a 
theoretical framework for the project.  The second paper describes the Integrative Model of 
Behavior Change and the three-step process used to motivate and encourage behavior change. 
With the purpose clearly defined and a strong theoretical foundation, the scholarly project was 
planned, implemented, evaluated, and disseminated.  The final paper describes that process.    
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 The work reflected in these papers is a beginning with the potential to positively impact 
the health of African Americans with hypertension in a small rural community.  Perhaps the 
beginning work will spread beyond this single community.  The author is encouraged about the 
potential of this work to continue positive influence on health. 
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Abstract 
Background: Rates of medication adherence are low among hypertensive blacks despite 
numerous interventions to increase their adherence. Purpose: The aim of this paper was to 
conduct a review of literature to identify the published barriers to medication adherence in 
African-American patients with hypertension and to review the published interventions and 
strategies used to create success. Methods: A systematic computer search of qualitative and 
quantitative studies was performed that examined factors associated with medication adherence 
and interventions used in hypertensive African Americans from 2001 to 2013. Studies were 
included if medication adherence was either the primary or secondary outcome variable. Results: 
Selected studies (n = 27). Conclusion: Barriers to medication adherence included patient, 
therapy, and provider related barriers. Interventions that were associated with medication 
adherence included three main categories: pharmacy based, nurse led, and patient related.  
     Keywords: hypertension, medication adherence, African Americans, interventions 
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One in four adults has hypertension (HTN), which highlights the prevalence of HTN as a 
wide spread problem (Fernandez, et al., 2011).  African Americans have a higher prevalence and 
greater severity of HTN than do other minorities and Caucasians. The prevalence of HTN in 
African Americans is among the highest in the world. HTN develops earlier in life and average 
blood pressures (BPs) are much higher in African Americans than in Caucasians. African 
Americans also have higher rates of stage-3 HTN, causing a greater burden of HTN 
complications (Artinian, Washington, & Templin, 2001).  Although scientific evidence has 
established an array of both non-pharmacologic and pharmacologic strategies that reduce BP, the 
rate of awareness, treatment, and control of HTN in the US population is declining, increasing 
danger for African American in particular (Frinkelstein & Cha, 2009). Non-adherence to 
prescribed medications threatens the health and well-being of patients and has costly financial 
implications. Medication non-adherence causes the death of nearly 125,000 Americans every 
year and has been linked to an estimated 10% of hospital and 23% of nursing-home admissions 
(Migneault, Dedier, Wright, Heeren, Campbell, Morisky, Rudd, & Friedman, 2012).  
According to a 2003 report by the World Health Organization (WHO), medication 
adherence is the extent to which a person’s behavior in taking medications corresponds with the 
agreed communication of their health care provider (Brown & Bussell, 2011). Therefore, 
medication adherence is one of the most important factors in keeping the vital link between the 
treatment and the therapeutic outcomes in medical care. To achieve better BP control in African 
Americans, optimal medication adherence must be achieved. Unfortunately, medication non-
adherence rates are high among African Americans, and there is indication that non-adherence 
rates for African American are worse when compared with Caucasians (Artinian et al., 2001). 
Non-adherence has been associated with misunderstanding of the condition, perceived 
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improvement in health, worsening in health, general disapproval of medications, and concern 
over side effects (Nair, et al., 2011). Many of the instances of patients not taking medicines to 
minimize side effects are pragmatic. For the majority of patients who have no symptoms with 
hypertension, the fact that they do not feel unwell may encourage non-adherence. Side effects 
may be unacceptable in a condition that is asymptomatic. The number of medicines prescribed 
may also influence adherence, with a reduction in compliance as the regime becomes more 
complex (Artinian et al., 2001). The aim of this paper was to conduct a review to identify 
published barriers to medication adherence in African-American patients with hypertension and 
to review the published interventions and strategies used to create success. 
Methods 
     The MEDLINE, CINAHL (Cumulative Index to Nursing and Allied Health), and Academic 
Search Premier databases literature search was limited to English articles published between 
2003 and 2013 using the following terms: medication adherence, interventions, hypertension and 
African Americans. Additional references were obtained from citations within the retrieved 
articles. Qualitative or quantitative studies that identified barriers to medication adherence in 
African Americans and the interventions used to create success were the major focus of this 
literature review. Studies that examined racial disparities in medication adherence and reported 
on factors associated with adherence in African Americans were included in this literature 
review. Inclusion criteria were: 1) African Americans with hypertension, 2) prescribed 
medication treatment for high blood pressure, and 3) peer-reviewed articles. The majority of 
articles screened and excluded were quantitative studies that did not measure medication 
adherence as a study outcome.  
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Results 
     A total of 56 citations from the databases were identified. After screening the abstracts for 
their relevance and eliminating duplicate records, 22 articles were reviewed. Another five articles 
were added after reviewing the references of the selected literature. The final number of articles 
included in this review was 27.  Ten (10 of 27, 37%) examined patient related barriers to 
medication adherence (Table 1).  Four studies (4 of 27, 15%) examined therapy related barriers   
(Table 2), and four studies (4 of 27, 15%) examined provider related barriers to medication 
adherence (Table 3). There were seven studies (7 of 27, 30%) that examined interventions used 
to increase medication adherence. Three (3 of 7, 43%) examined patient related interventions 
(Table 4). Two (2 of 7, 30%) examined nurse-based interventions (Table 5), and two (2 of 7, 
30%) examined pharmacy related interventions (Table 6).  Some studies fit in multiple sections. 
Patient-related Barriers 
Gender 
     According to Courtenay, McCreary, and Merighi (2002), men are less likely than women to 
engage in a variety of preventive and self-care techniques, and the failure to do so contributes to 
men’s increased health risks. Not only are men less likely than women to restrict their activities 
or stay in bed when they are suffering from acute or chronic conditions, but also they are less 
likely to persist in caring for a major health problem (Courtenay et al., 2002) In their cross-
sectional study, Shea and colleagues (2002) found that men were more likely to be nonadherent 
to their antihypertensive medications than were women, and that women are more likely than 
men to engage in a variety of health- promoting behaviors and healthier life- style patterns. Four 
additional articles found no association between gender and medication adherence (Lague, et al., 
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2009; Lukoscheck, 2003; Krousel-Woods, Muntner, and Joyce, 2010; Turner, Hollenbeak, 
Weiner, Ten Have, & Roberts, 2009). See Table 1. 
Knowledge 
     It is arguably, surprising to discover that patients with a chronic condition, such as 
hypertension, lack basic knowledge about its potential risks and medication’s positive role even 
in the absence of symptoms. The patient’s knowledge and awareness of hypertension was 
significantly associated with compliance to medication for hypertension (Al-Meza, Al-Muhailije, 
Khalfah, & AL-Yahya, 2009).  This correlation highlights the importance of health education to 
increase the knowledge of hypertension in order to improve the patient’s compliant behavior. 
Patel and Taylor (2002) report that patients who knew the importance of compliance had a 
significantly higher compliance rate than those who were ignorant of that aspect. Findings from 
the qualitative studies reported themes that described patients who believed that the absence of 
HTN symptoms influenced them to become nonadherent (Ferdinand, 2009; Gascon, Sanchez-
Ortuno, Llor, Skidmore, & Saturno, 2004; Lukoschek, 2003). In a cross-sectional study 
examining comorbidities and medication adherence in blacks, Lague and colleagues (2009) 
found that those patients having stage 2 HTN (either systolic BP >159 mm Hg or diastolic BP 
>99 mm Hg) were more likely to have better adherence.  Stage 2 hypertension is severe and 
requires immediate medical attention. Without medication, serious complications can occur such 
as blood vessel rupture, swelling of the brain and kidney failure (Lague et al., 2009). If the 
patient were to experience any symptoms at this stage, they may encounter dizzy spells, blurry 
vision (visual disturbance), headache or nausea. See Table 1. 
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Therapy-related Barriers 
     Therapy-related factors include the complexity of the medical regimen, duration of treatment, 
frequent changes in treatment, and adverse effects (Fongwa, Evangelisa, Hays, Martins, 
Elaghoff, Cowan & Morisky, 2008). Studies examining therapy-related factors to medication 
adherence among hypertensive African Americans have been primarily qualitative. In these 
qualitative studies, patients have described medication adverse side effects as causing adjustment 
to antihypertensive medication dosages including discontinuation (Gascon et al., 2004). Complex 
treatment is believed to threaten the patient’s compliance. However, compliance does not seem 
to correlate with the number of drugs prescribed, but the number of dosing times every day of all 
prescribed medication (Ren, Kazis, Lee, Zhang, & Miller, 2002). Medications with once-daily 
dosing may be preferable to medications with multiple doses per day because minimizing the 
frequency of dosing has been shown to improve adherence (Schroeder, Fahey, & Ebram, 2004). 
See Table 2. 
Provider-related Barriers 
    Healthcare providers play an integral role in medication adherence. Patients who trust their 
physicians have better two-way communication with their physician. Trust and communication 
are two elements critical in optimizing adherence. . Numerous studies show that provider trust is 
more important than treatment satisfaction in predicting adherence to prescribed therapy and 
overall satisfaction with care (Piette, Heisler, Krein, & Kerr, 2005). Physician trust correlates 
positively with acceptance of new medications, intention to follow physician instructions, 
perceived effectiveness of care, and improvements in self-reported health status (Piette, et al., 
2005). Haskard and DiMatteo (2009) found that there is a 19% higher risk of non-adherence 
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among patients whose physician communicates poorly than among patients whose physician 
communicates well. Statistically, the odds of patient adherence are 2.26 times higher if a 
physician communicates well (Haskard & DiMatteo 2009). A qualitative study by Lukoshek 
(2003) found that patients describing their beliefs that quality of communication with their 
healthcare providers was an important influence on their medication adherence. Quantitative 
studies supported qualitative findings and have reported that patients with healthcare providers 
who are empathetic, nonjudgmental, and collaborative are significantly more likely to adhere to 
their medications (Odedosu, Schoenthaler, Vieira, Agyemang, & Ogedegbe, 2012). See Table 3. 
Interventions 
Patient-based Interventions 
The most common approaches to improving blood pressure control at the patient level 
regardless of race is patient education to address misconceptions about hypertension and to 
improve adherence to drug therapy (Odedosu et al., 2012).  In trying to overcome patient-related 
barriers, emphasis should be on patient education, in particular addressing misconceptions about 
hypertension and promoting adherence to antihypertensive therapy. According to Odedosu et al., 
(2012), patient education can improve blood pressure and its aims are to increase patients’ 
understanding of the disease and to encourage them to be more active in their own care. 
Computer interventions have emerged as an effective approach to increasing health 
knowledge, health- related skills, and health outcomes (Odedosu et al., 2012). Migneault et al., 
(2012) evaluated a culturally adapted, automated telephone system to help hypertensive, urban 
African– American adults improve their adherence to their antihypertensive medication regimen 
and to evidence-based guidelines for dietary behavior and physical activity. The totally 
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automated, computer-based, interactive telephone counseling system, called Telephone-Linked-
Care, monitored, educated, and counseled African–American adults with hypertension and 
provided summary data regularly to the patient’s primary care provider (Migneault et al., 2012). 
The automated service was associated with improvements in overall diet quality and energy 
expenditure. A decrease in systolic BP between groups was not statistically significant (−2.3 
mmHg, p = 0.25). Although the treatment group’s adjusted 7-item Morisky Medication 
Adherence Scale scores improved by 0.19 points relative to controls, this change was not 
statistically significant (p = 0.25) (Migneault et al., 2012). 
Motivational interviewing is a promising patient-centered approach for improving 
adherence in patients with chronic disease. Motivational interviewing is defined as a directive, 
patient-centered approach to counseling designed to motivate people for change by helping them 
to recognize and resolve the discrepancy between their present behavior, and their future 
personal goals and values (Obedegbe, Chaplin, Schoenthaler, et al., 2008). Motivational 
interviewing is composed of principles and techniques drawn from various theoretical 
paradigms, the most important of which are its patient-centeredness, its ability to enhance 
patient's self-efficacy, and its focus on patients' readiness to change behavior.  Ogedegbe et al., 
(2008) randomized 190 hypertensive African American patients to receive usual care or quarterly 
counseling sessions that used motivational interviewing focused on medication adherence. The 
counseled patients stayed adherent to their medications, whereas adherence declined 
significantly in those receiving usual care. This effect was associated with a modest, non-
significant trend toward a net reduction in systolic blood pressure with motivational 
interviewing. See Table 4. 
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Nurse-based Interventions 
Bosworth, Olsen, Grubber, et al., (2009) study of a practice in which almost half the 
patients were African American, randomized patients to receive usual care, nurse-administered 
tailored behavioral telephone counseling, home blood pressure monitoring, or home monitoring 
plus tailored behavioral telephone counseling. Bosworth et al., (2009) found that a combination 
of home monitoring and tailored behavioral telephone counseling led to a statistically significant 
improvement in blood pressure control at 24 months compared with baseline. Artinian et al., 
(2001) evaluated the effect of nurse-managed telemonitoring on blood pressure control vs. 
enhanced usual care. The monitored group had a significantly greater reduction in systolic 
pressure at 12 months compared with those who received enhanced usual care. See Table 5. 
Pharmacy-based Interventions 
Pharmaceutical interventions have been shown to improve the BP control in hypertensive 
patients by increasing the appropriateness of prescribing and adherence to treatment. Ramanath, 
Nagakishore, & Kumar, (2012) study showed that clinical pharmacist intervention among a rural 
population has a very strong positive impact in creating awareness about the disease, and its 
maintenance by increasing their medication adherence. Hunt, Siemienczuk, Pape, et al., (2008) 
conducted a randomized controlled trial in which pharmacists actively participated in the 
management of blood pressure. The pharmacists reviewed medications and adverse drug 
reactions, assessed lifestyle behaviors and barriers to adherence, made dosing adjustments, and 
added medications. Patients randomized to the intervention group achieved significantly lower 
systolic and diastolic pressures (137/75 vs. 143/78 mm Hg in the control group). However, 
information about race was not included. See Table 6. 
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Conclusion 
     The purpose of this paper was to determine the factors associated with medication adherence 
in hypertensive African Americans and successful interventions. Barriers associated with non-
adherence included patient, physician, and therapy related barriers. Medication adherence is 
primarily in the domain of the patient. Because patients recall as little as 50% of what is 
discussed during the typical medical encounter, effective patient education must be 
multifactorial, individualized, and delivered in a variety of methods and settings outside of the 
examining room (WHO, 2003). A key component of any adherence-improving plan is patient 
education. 
The substantially improved adherence of patients who report a good relationship with 
their physician highlights the important role of physicians in the medication adherence equation. 
Similar to any relationship, one key to a good physician-patient relationship is effective 
communication. Thus, perhaps the foremost strategy providers can use to increase medication 
adherence is to follow a patient-centered approach to care that promotes active patient 
involvement in the chronic disease management decision–making process. 
  Addressing therapy-related factors should contribute positively in improving patient 
compliance. Prescribing medication with non-invasive route of administration (eg, oral 
medication) and simple dosing regimens might motivate patients to be compliant. Long duration 
of treatment period and medication side effects might compromise patient’s beliefs about 
medication effectiveness (Jin, Sklar, On, & Li, 2008). Therefore, healthcare providers should 
consider therapy-related problems when designing the therapy plan and involve the patients in 
the process to minimize the possible therapeutic barriers. 
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Although there is a growing body of literature on interventions to reduce disparities in 
hypertension and blood pressure control between African Americans and Caucasians, gaps in the 
literature still exists. Only a few randomized controlled trials have focused on African 
Americans. The majority of articles used in this review are not considered recent (within past 5 
years), and this may be related to a number of factors. First, there may be a professional 
disinterest in hypertension in the African American community. Hypertension in this population 
has been an ongoing problem for decades and researchers may have turned their attention to 
other pressing issues that are affecting the population as a whole.  Secondly, because changing 
ones behavior is challenging, researchers may be reluctant to tackle such a recalcitrant task. 
However, the work must continue in order to positively impact the health of hypertensive 
African Americans. While interventions for improving medication adherence have successfully 
enhanced adherence in the short-term, the findings for longer-term chronic disease medication 
are discouraging. Furthermore, the majority of interventions designed to improve adherence have 
been conducted in urban settings, and thus, little is known of their effectiveness in rural areas. 
More research is needed to better understand the optimal combination of interventions and user 
characteristics to improve medication adherence among hypertensive African Americans in a 
rural setting. 
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Table 1: Patient-related barriers to medication adherence 
 
Author and Journal 
 
 
Sample Methods Findings 
Al-Mehza, A, Al-Muhailije, 
F. (2009). European 
Journal of General 
Medicine 6(1), 6-10 
There were 154 hypertensive 
patients from a hypertension 
clinic in Kuwait were 
followed for 6 months 
Three BP measures were in 
an interval of at least 4 weeks 
after being on meds for at 
least 3 months. Participants 
were labeled un-controlled 
hypertensive if the mean of 
the three measures of SBP 
≥140mmHG and/or DBP was 
≥90mmHG. Self-report and 
pill count measured 
participant’s non-compliance. 
Subjects who had consumed 
less than 80% of the 
prescribed drugs were labeled 
as being non-compliant. 
Non-compliance was a significant 
predictor for uncontrolled 
hypertension. Knowledge and 
awareness of HTN was significantly 
associated with compliance. More than 
half of the non-compliant patients 
reported forgetfulness and absence of 
symptoms of HTN as reasons for their 
non-compliance.  
Courtenay, W., McCreary, 
R. & Merighi, J. (2002). 
Journal of Health 
Psychology, 7(3), 219-231 
A convenience sample of 
1816 undergraduate students, 
ranging in age from 18 to 72 
years (M = 22 years, SD = 6 
years), was recruited from 
three four-year, English-
language, California public 
universities. The sample was 
comprised of 60 percent 
women. Thirty-seven percent 
of the sample was Asian 
American, 28 percent 
European American, 18 
To assess health risk 
behaviors, a series of seven 
behavioral and three 
attitudinal/belief domains 
were identified. A list of 
behaviors or beliefs was then 
generated for each domain. A 
total of 48 items were 
produced in all. The seven 
behavioral domains were: 
diet, exercise and fitness, 
substance use, preventive 
care, social support, safety, 
Men were more likely than women to 
engage in behaviors and adopt beliefs 
that were detrimental to their health. A 
secondary finding was that many of the 
health risk behaviors examined were 
intercorrelated. For example, Diet was 
positively correlated with Anger and 
Stress, Preventive Care, Medical 
Compliance and Substance Use; the 
Anger and Stress domain was also 
correlated with both Preventive Care 
and Substance Use. 
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percent Hispanic, 6 percent 
African American and 12 
percent reported their 
ethnicity as Other (e.g. 
Middle Eastern) or Mixed 
Heritage 
 
and anger and stress. 
 
Ferdinand, K. (2009). 
Cardiology Review, 26(1), 
17-19 
 
NA NA Adherence to antihypertensive 
medication regimens is difficult, 
especially in African Americans. Lack 
of adherence to blood pressure 
medications predicts poor control and 
is one of the underlying factors for the 
serious health disparities regarding 
morbidity and morality observed in 
African Americans. 
Gascon, J., Sanchez-Ortuno, 
M., Skidmore, L., & 
Saturno, J. Family Practice, 
21(2), 125-130 
Non-compliant hypertensive 
patients diagnosed with and 
receiving treatment for 
hypertension. Inclusion 
criteria were anyone ages of 
18-80yrs, being treated with 
anti-hypertensive for 
>3months, being non-
compliant and having 
sufficiently good physical 
and mental health. 
A qualitative study with 
seven focus groups 
discussions conducted in 
March-May 2001. Patients 
were identified as non-
compliant, using the 
Morisky-Green test at two 
primary health care centers of 
the Spanish National Health 
Services. 
A complex web of factors influenced 
non-compliance including fears and 
negative images of anti-hypertensive 
drugs and lack of basic background 
knowledge about hypertension. The 
clinical encounter was unsatisfactory 
because of length, few explanations 
given by the physician and low 
physician-patient interaction 
Krousel-Wood, M., 
Muntner P, Joyce, C. et al. 
(2010). Journal of 
American Geriatrics 
Society, (58)1, 54-61. 
2180 black and white adults 
aged 65 and older and 
prescribed antihypertensive 
medication. 
A cross sectional design. 
Information on CAM use 
(health food and herbal 
supplements, relaxation 
techniques) for blood 
In this cohort of older managed care 
patients, CAM use was associated with 
low adherence to antihypertensive 
medication in blacks but not whites.  
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 pressure control and 
antihypertensive medication 
adherence were collected in a 
telephone survey between 
August 2006 and September 
2007. Low medication 
adherence was defined as a 
score less than 6 using the 
eight-item Morisky 
Medication Adherence Scale.  
 
 
Lague,T., Weiner, M., 
Eachus, S., Tang, S., 
Schwartz, J., & Turner, B. 
(2009). American Journal 
of Managed Care, 15(1), 
24-30 
 
327 African Americans aged 
>or=18 years 
 
Cross-sectional study of 
patients enrolled in a 
Medicaid managed care plan 
and treated in 6 primary care 
practices. Prescription filling 
was defined as a match 
between a new or renewed 
electronic prescription and an 
insurance claim within the 30 
days. The study assessed the 
association of comorbidity 
type with filling an 
antihypertensive prescription 
by using an adjusted logistic 
regression model that 
accounted for clustering of 
prescriptions within patients. 
 
1. Age 50 years or younger was 
associated with lower 
adherence.  
2. Having 5 or more non-
cardiovascular comorbidities 
was associated with higher 
adherence. 
3. Cardiovascular comorbidities 
were not associated with 
adherence. 
4. Having stage 2 hypertension 
was significantly associated 
with higher adherence. 
Lukoscheck,P. (2003). 
Journal of Health Care for 
Hypertensive African 
Americans were recruited 
A qualitative study to explore 
hypertensive African 
Themes identified that adherence may 
be influenced by: 1. Adaptation and 
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the Poor and Underserved, 
14(4), 566-587. 
from an urban, public 
hospital and divided into two 
categories: adherent, well-
controlled versus non-
adherent, poorly controlled 
participants 
Americans beliefs and 
attitudes regarding 
hypertension that might serve 
as barriers to hypertension. 
preservation of health beliefs, 2. 
Absence of disease symptoms. 3. 
Distrust, stress, and perception of 
racial prejudice, and 4. Patient-
provider relationship. 
Patel, K., & Taylor, S. 
(2002). Annals of 
Pharmacotherapy, 36(1), 
40-45 
Patients were recruited from 
the University of Michigan 
hypertensive clinic. 
Inclusion: 1. >18 years 2. 
Regular attendance at the 
clinic 3. Diagnosis of 
hypertension within 1 year 
prior to completing the study, 
and 4. A goal to reduce 
hypertension. There were 102 
participants with 46 males 
and 56 females. 
A prospective, cross sectional 
survey of hypertensive 
patients assessed patients’ 
health beliefs, illness 
attributions, and perceived 
control. Six months later a 
follow-up telephone survey 
determined medication 
adherence.  
Patients indicated that modifiable 
variables were the most common 
attribution believed to cause 
hypertension; however, there was no 
significant relationship to medication 
adherence.  
Shea, S., Misera, D., 
Ehrlich, M., Field, L., & 
Francis, C. (2002). 
American Journal of Public 
Health, 82(12), 1607-1612. 
Subjects (n = 202) were 
interviewed as part of a case-
control study of severe, 
uncontrolled hypertension 
conducted in two New York 
City hospitals. All subjects 
were African American or 
Hispanic. 
Self-reported non-adherence 
to drug treatment for 
hypertension was measured 
using a five-item scale, and 
the sample was dichotomized 
as more (n = 87) or less (n = 
115) adherent. Multiple 
logistic regression analysis 
was used to adjust for 
demographic and other 
covariates. 
Changing the locus of care for 
hypertension from emergency rooms to 
primary care physicians may improve 
adherence to hypertension treatment in 
minority populations. 
 
Turner B., Hollenbeak, C., 
Weiner, M., Ten Have T., & 
Roberts, C.(2009), 
Pharmacoepidemiology & 
300 hypertensive patients 
aged >70 from four urban 
primary care practices.  
Participant’s annual mean 
systolic blood pressure was 
calculated from electronic 
records. Subjects were asked 
Self-reported adherence was associated 
with a higher blood pressure, 
especially in elderly black patients. To 
promote adherence data suggest 
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Drug Safety, (18) 8, 672-
681 
 about the last missed 
antihypertensive dose in six 
time intervals. Based on 
association with blood 
pressure control, non-
adherence was defined as 
missing any dose in the past 3 
months. Subjects were also 
asked about six domains of 
adherence barriers: health, 
personal support, drug 
coverage, medication filling 
and use, doctor–patient 
interaction and knowledge. 
All models were adjusted for 
demographics, treatment 
regimen, and sampling 
weights.  
 
targeting the filling of prescriptions, 
prioritizing hypertension care and 
educating about effects of 
hypertension.  
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Table 2: Therapy-related barriers to medication adherence 
 
Author & Journal Sample Methods Findings 
Fongwa, M., Evangelisa, L., 
Hays, R., (2008). Vascular 
Health and Risk Management 
4(1), 157-166 
African American women 
receiving treatment for the 
disease from an ambulatory 
inner-city free clinic in West 
Los Angeles. Five focus group 
interviews were conducted with 
20 hypertensive African 
American women, 35 years and 
older.  
 
Qualitative study in which 
transcripts from the tapes were 
analyzed for content describing 
adherence to treatment factors. 
 
Factors associated with 
adherence to treatment included 
beliefs about hypertension, 
facilitators of adherence to 
treatment, and barriers to 
adherence to treatment. 
Recommendations included 
need for culturally sensitive 
education on managing 
hypertension and medication 
side effects, early screening for 
depression. 
Gascon, J., Sanchez-Ortuno, 
M., Skidmore, L., & Saturno, J. 
Family Practice, 21(2), 125-
130 
Non-compliant hypertensive 
patients diagnosed with and 
receiving treatment for 
hypertension. Inclusion criteria 
were anyone ages of 18-80yrs, 
being treated with anti-
hypertensive for >3monts, 
being non-compliant and 
having sufficiently good 
physical and mental health. 
A qualitative study with seven 
focus groups discussions 
conducted in March-May 2001. 
Patients were identified as non-
compliant, using the Morisky-
Green test at two primary 
health care centers of the 
Spanish National Health 
Services. 
A complex web of factors 
influenced non-compliance 
including fears and negative 
images of anti-hypertensive 
drugs also a lack of basic 
background knowledge about 
hypertension. The clinical 
encounter was viewed as 
unsatisfactory because of 
length, few explanations given 
by the physician and low 
physician-patient interaction. 
Ren, X., Kazis, L., Lee, A., 
Zhang, H., & Miller, D. (2002) 
Journal of Clinical Pharmacy 
and Therapeutics, 27(1), 47-56 
Prescription records from 
patients who were in the 
Veterans Health Study (VHS). 
2425 patients agreed to 
Participants completed the 
Veterans Short-Form Health 
Survey, plus in person 
interview. Within a month they 
Number of medications was 
positively associated with 
compliance. Patient who were 
more involved in treatment 
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 participate.  completed a physical exam, 
clinical assessment, and a 
medical history. Patients’ self-
reported medication 
compliance included four 
questions, originally developed 
and validated by Morisky and 
colleagues. 
decisions were more compliant 
than those who were less 
involved in treatment decisions. 
Physician’s age had a negative 
effect on compliance. 
Schroeder, K., Fahey, T., & 
Ebram, S. (2004). Archives of 
Internal Medicine, 164(7), 722-
732. 
  A systematic review of 
randomized controlled trials. 38 
studies testing 58 different 
interventions and containing 
data on 15,519 patients. The 
studies were conducted in 9 
countries between 1975 and 
2000. 
Reducing the number of daily 
doses appears to be effective in 
increasing adherence to blood 
pressure-lowering medication 
and should be tried as a first-
line strategy. Some 
motivational strategies and 
complex interventions appear 
promising. 
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Table 3: Provider-related barriers to medication adherence 
 
 
Author and Journal Sample  Method Findings 
Haskard Zolnierek, K., & 
DiMatteo, R. (2009). Medical 
Care. 47(8), 826-834. 
Database searched yielded 128 
articles which focused on 
adherence and communication 
Meta-analysis of 106 
correlational studies and 
21interventional studies 
evaluating the effects of 
physician communication 
training on the outcome of 
patient adherence.  
Physician communication is 
significantly positively 
correlated with patient 
adherence. Training physicians 
in communication skills 
resulted in improvements in 
patient adherence. With 
training the odds of patient 
adherence are 1.62 times 
higher. 
 
Odedosu,T., Schoenthaler, A., 
Vieira, D., Agyemang, C., & 
Ogedegbe, G. (2012) Cleveland 
Clinic Journal of Medicine, 
79(1), 46-56 
 
A data search yielded articles 
focused on barriers to 
hypertension control in African 
Americans and interventions 
used to create success. No 
number was reported for 
articles used.  
A systematic review focusing 
on barriers to hypertension in 
African Americans and 
interventions used. 
Barriers contributing to 
patient’s non-compliance were 
patient r/t (lack of knowledge, 
inability to engage in lifestyle 
modification, health beliefs, & 
medication side effects), 
physician-r/t (non-adherence to 
treatment guidelines, failure to 
emphasize lifestyle 
modifications), health care 
system r/t (lack of access to 
care, high cost of medications). 
Recommendations to overcome 
theses barriers should focus on 
patient education, self –
monitoring with a home blood 
pressure monitor, behavioral 
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counseling, and physician-
related interventions. 
Piette, J.D. Heisler, M., & 
Krein, S., & Kerr, E. (2005).  
Archives of Internal Medicine, 
165(15): 1749-1755.  
 
912 patients with diabetes 
recruited from 5 Veterans 
Affairs health systems.  
A detailed cross-sectional 
survey where patients reported 
their level of physician trust. 
Results were stratified into 
high-trust (n = 557) and low 
trust (n = 355). 
A trusting physician 
relationship may moderate the 
impact of cost pressures on 
patients' medication adherence. 
Addressing non-cost barriers to 
adherence may reduce rates of 
cost-related medication 
underuse. 
Lukoscheck,P. (2003). Journal 
of Health Care for the Poor 
and Underserved, 14(4), 566-
587. 
Hypertensive African 
Americans were recruited from 
an urban, public hospital and 
divided into two categories: 
adherent, well-controlled 
versus non-adherent, poorly 
controlled participants. 
A qualitative study to explore 
hypertensive African 
Americans beliefs and attitudes 
regarding hypertension that 
might serve as barriers to 
hypertension. 
Themes influencing adherence 
included: 1. Adaptation and 
preservation of health beliefs, 
2. Absence of disease 
symptoms. 3. Distrust, stress, 
and perception of racial 
prejudice, and 4. Patient-
provider relationship. 
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Table 4: Patient- Related Interventions 
 
Author and Journal Sample Method Findings 
Odedosu,T., Schoenthaler, A., 
Vieira, D., Agyemang, C., & 
Ogedegbe, G. (2012) Cleveland 
Clinic Journal of Medicine, 
79(1), 46-56 
 
A data search yielded articles 
on barriers to hypertension 
control in African Americans 
and interventions used to create 
success. No number was given 
for the amount of articles used. 
A systematic review focused on 
barriers to hypertension in 
African Americans and 
interventions used. 
Barriers that contributed to 
patient’s non-compliance, were 
patient r/t (lack of knowledge, 
inability to engage in lifestyle 
modification, health beliefs, & 
medication side effects), 
physician-r/t (non-adherence to 
treatment guidelines, failure to 
emphasize lifestyle 
modifications), health care 
system r/t (lack of access to 
care, high cost of medications). 
Recommendations to overcome 
these barriers should focus on 
patient education, self –
monitoring with a home blood 
pressure monitor, behavioral 
counseling, and physician-
related interventions. 
Obedegbe, G. et al., (2008). 
American Journal of 
Hypertension, 21(10), 1137-
1143. 
190 hypertensive African 
Americans (88% women; mean 
age 54 years). Patients were 
recruited from two community-
based primary care practices in 
New York City. 
Randomized controlled trial of 
a practice-based MINT 
counseling vs. usual care (UC) 
on medication adherence and 
blood pressure (BP). Outcomes 
were adherence measured by 
electronic pill monitors; the 
secondary outcome was within-
patient change in office BP 
from baseline to 12 months. 
MINT counseling led to steady 
maintenance of medication 
adherence over time, compared 
to significant decline in 
adherence for UC patients.  
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Migneault, J. et al. (2012). 
Annals of Behavioral Medicine, 
43(1), 62-73. 
 
337 participants from a large, 
urban safety-net hospital and 
community health centers. 
Inclusion criteria were: (a) 
African–American; (b) 
diagnosis of hypertension on 
the active problem list of the 
patient’s medical chart; (c) 
current prescription for ≥1 
antihypertensive medications; 
(d) ≥1 primary care office visits 
in the previous 2 months; (e) 
two elevated clinic BP readings 
in the previous 6 months 
(systolic blood pressure ≥140 
mmHg and/or diastolic blood 
pressure ≥90 mmHg among 
non- diabetic patients, and 
≥130/80 among diabetic 
patients); and (f) age ≥35 years.  
 
Randomized 337 patients to an 
8-month automated, multi-
behavior intervention or to an 
education-only control. 
Medication adherence, diet, 
physical activity, and BP were 
assessed at baseline and every 4 
months for 1 year. Data were 
analyzed using longitudinal 
modeling. 
Automated telecommunications 
systems can promote self-
management of diet and energy 
balance in urban African–
Americans.  
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Table 5: Nurse-Based Interventions 
 
 
Author and Journal Sample Method Findings 
Artinian, N., Washington, O., 
& Templin, T. (2001).  Heart 
and Lung 
 
26 participants—3 (11.5%) 
men and 23 (88.5%) women—
had a mean age of 59 years, 
with a range of 32 to 93 years. 
All participants were African 
American. 
Pilot study with randomized 
controlled design. Participants 
were assigned to 3 groups: 
home tele-monitoring plus 
usual care; community-based 
monitoring plus usual care; or 
usual care only. Stratification 
by use or nonuse of anti-
hypertension medication was 
used. 
 
Participants in the home tele-
monitoring and community-
based monitoring groups had 
clinically and statistically 
significant reductions in both 
SBP and DBP during a 3-
month monitoring period 
compared with the participants 
in the usual care group. 
 
Bosworth, H. et al., (2009). 
Annals of Internal Medicine, 
151 (10),  687-w224. 
636 Hypertensive patients Randomized patients received 
usual care, a behavioral 
intervention (bimonthly 
tailored, nurse-administered 
telephone intervention targeting 
hypertension-related 
behaviors), home BP 
monitoring 3 times weekly, or 
the behavioral intervention plus 
home BP monitoring.   
Combined home BP monitoring 
and tailored behavioral 
telephone intervention 
improved BP control, systolic 
BP, and diastolic BP at 24 
months relative to usual care. 
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Table 6: Pharmacy-Based Interventions 
 
 
 
 
Hunt, J. et al., (2008). Journal 
of General Internal Medicine, 
23(12), 1966-1972. 
 
In the Providence Primary Care 
Research Network of patients 
with hypertension and 
uncontrolled blood pressure.    
 
Pharmacy practitioners 
participated in the active 
management of hypertension in 
the primary care office 
according to established 
collaborative treatment 
protocols. Outcome measures 
were the differences in mean 
systolic and diastolic blood 
pressures between arms at 
study end and blood pressure 
goal attainment (< 140/90 
mmHg), hypertension-related 
knowledge, medication 
adherence, home blood 
pressure monitoring, resource 
utilization, quality of life, and 
satisfaction. 
Patients achieved significantly 
better blood pressure control 
compared to usual care with no 
difference in quality of life or 
satisfaction. 
 
Ramanath, B., Nagakishore, C.,  
& Kumar, M. (2012). Archives 
of Pharmacy 
Fifty-six patients were enrolled; 
only 52 patients completed the 
study. Race was not specified.  
Prospective, randomized 
interventional study. 
Interventional group patients 
received patient counseling, 
patient information leaflets 
(PILS), and frequent telephone 
reminders. Medication 
adherence and QOL were 
assessed with the Morisky 
Medication Adherence Scale 
Clinical pharmacist patient 
counseling had a positive 
impact on medication 
adherence and QOL. 
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(MMAS) and Medication 
Adherence Report Scale 
(MARS) Questionnaires and 
SF-12v2 Quality of life 
Questionnaire. 
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Clinical Practice Model: Integrative Model of Behavior Change  
Laneita Davis, FNP-BC, DNP-candidate 
Belmont University 
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One of the most prevalent and serious health issues among African-American patients is 
hypertension. Though a large percentage of the population has hypertension, many do not follow 
prescribed treatments or take medication for the condition. Statistics show that individuals of 
African-American descent are more likely to develop hypertension than any other ethnicity in the 
United States with about 43 percent of African-American men and 45 percent of African-
American women affected by the condition (Center for Disease Control [CDC], 2012). In 
comparison, a national average of those suffering with this condition is 34 percent of men and 32 
percent of women (CDC, 2012). Clearly, African Americans have a higher prevalence of this 
serious illness.  When left untreated, hypertension may result in life-threatening complication 
including abdominal aortic aneurysm, chronic kidney disease, cardiac arrest, stroke, loss of 
vision, or peripheral artery disease (CDC, 2012). However, despite the grave potential 
consequences of leaving hypertension untreated, only seven out of ten Americans with the 
condition use medication to control their high blood pressure (CDC, 2012). The Integrative 
Model of Behavioral Prediction uses a reasoned action approach to understand behavior. The 
model purports that although an infinite number of variables may in some way influence 
behavior, only a small number of variables need to be considered to predict, change, or reinforce 
a particular behavior in a particular population (Fishbein & Ajzen, 2010). This paper proposes an 
intervention based on the Integrative Model of Behavioral Prediction, also known as I-Change 
model. The I-Change model is a method used in modifying behavior that is easy to implement 
and effective in changing behavior.  The proposed intervention employs the I-Change Model as a 
framework for persuading patients to take their hypertension medication as prescribed. 
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Theoretical Framework 
The Integrative Model of Behavior Change (I-Change Model) is the most recent 
formulation of Fishbein and Ajzen’s (2010) reasoned action approach. The development of the 
reasoned action approach has been sequential. Early work by Martin Fishbein in the 1960s 
focused on conceptual differences between beliefs, attitude, and intention constructs in response 
to scholars who doubted the usefulness of the attitude construct for predicting human behavior     
(Fishbein & Ajzen, 2010). This early work informed the theory of reasoned action, which models 
beliefs about particular outcomes and referents’ approval regarding the behavior as antecedents, 
and intentions and behaviors as consequences of attitude (Fishbein & Ajzen, 2010). In the 1980s, 
Icek Ajzen proposed the theory of planned behavior, which models perceived control over 
behavioral performance as an additional behavioral determinant next to attitude and subjective 
norm (Fishbein & Ajzen, 2010).   
The work of Fishbein and Ajzen resulted in another formulation of the theory which was 
proposed in 2000 as the Integrative Model of behavioral prediction (I-Change Model). The 
newest formulation extends the scope of the normative determinant and point’s attention to skills 
and environmental barriers as moderators of the intention–behavior relationship (Fishbein & 
Ajzen, 2010).  The I-Change Model assumes that the behavioral change process can be 
segmented into three phases: 1) Awareness, 2) Motivation, and 3) Behavior. The model describes 
a linear process toward behavior change. In the awareness phase, the participant becomes aware 
of their risk behavior. As the individual becomes aware of the personal consequences of their 
risky behavior, s/he may spend a significant amount of time thinking about the consequences of 
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the risky behavior. When awareness is created, understanding takes place. This understanding 
may help to change the individual’s attitude by developing a sense of responsibility for his/her 
behavior. The sense of responsibility can mature into a motivation to change the risky behavior. 
Important factors required to proceed through this phase, according to I- Change model, are 
knowledge, risk perceptions, and cues that prompt awareness (Broekhuizen, Van Poppel, 
Koppes, Brug, & Mechelen, 2010). In the motivation phase, a person becomes motivated to 
change his/her risky behavior. Important factors influencing motivation are attitudes, social 
support and self-efficacy expectations. Proceeding through the motivational phase results in 
positive intention to change one’s behavior. Intention to perform a behavior is a function of 
attitudes toward engaging in the behavior and perceived pressures to perform the behavior. In the 
final phase, motivation and intentions transition to changed behavior. For behavior change and 
maintenance, an individual attempts to convert his/her more global goal intentions into specific 
implementation intentions or action plans, with relevant strategies that will enable him/her to 
attain the desired goal of decreased risk (Broekhuizen et al. 2010). (See Figure 1). 
Literature Support 
 In the past, the I-Change model has proven to be effective in dealing with a variety of 
issues around the world. For example, in a skin cancer study conducted in Belgium, the I-Change 
model was used to facilitate behavior changes related to the usage of sunscreen lotion among 
teenagers (De Vries, Mesters, Riet, Willems & Reubsaet, 2006). De Vries and colleagues (2006) 
reported that the regular usage of sunscreen was found in individuals who became aware of the 
need to protect themselves from ultraviolet rays. The teens were motivated to be more careful 
while outdoors, and took the necessary precautions to make certain they were protected by using 
sunscreen and staying in the shade as much as possible.  The I-Change Model was helpful in 
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explaining the motivations and intentions of the individuals who were using sunscreen lotion in 
determining behavior change. This study’s results were beneficial in the development of 
programs that focused on skin cancer prevention and sunscreen promotion. 
Another example of the I-Change Model use is described in the 2005 study of De Vries 
and colleagues. The I-Change Model was used to analyze the general public’s need and 
perceptions concerning information on the role of hereditary factors on cancer development. The 
results from the study in 457 Dutch adults showed that 25% correctly indicated the types of 
cancer in which hereditary factors played a role (De Vries, Mesters, Steeg, & Honing, 2005). 
Using the I-Change Model was beneficial in determining the misconceptions regarding the 
importance of genetics and its influence on certain types of cancers. De Vries and colleagues 
(2005) analyzed levels of knowledge and interest regarding genetic information on hereditary 
cancer. Based on the analysis, the group recommended a program to increase awareness and 
recognition of potential hereditary predisposition in individuals. The study also found that 
carefully planned information activities were needed to increase general knowledge about cancer 
and cancer symptoms, and to establish correct perceptions of the types of cancer that have 
hereditary components and personal risks.  
The behavior change components of the I-Change model were a significant part of the 
process of abusive alcohol consumption when studied by a Dutch survey of frequent drinkers 
(Schulz, Kremers, & DeVries, 2012). The study found that for an individual who is attempting to 
discontinue drinking or consume less alcohol, the first and most important factor to consider was 
a change in his/her attitude towards drinking. Once the individual was made aware of his/her 
risky behavior and the consequences, the individual became motivated to change the risky 
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behavior.  The support of the people around him/her is a strong and positive factor in moving to 
the final step of behavior change. The final step of behavior change occurred when the drinker 
was motivated to the point of action, at which point the individual reported some form of success 
in achieving his/her goal (Schulz, Kremers, & DeVries, 2012). 
 The advantages of using this model are quite easy to see. The I-Change model can be 
used to correct almost any behavior in an individual with need. It is applicable to modifying 
behaviors related to smoking cessation, weight loss, or medication adherence. This model, unlike 
many others, can cross over socioeconomic, geographic or ethical barriers with ease. The only 
requirement is that an individual have a behavior s/he wants to change or modify. The 
individual’s background, occupation or home situation is irrelevant because the I-Change model 
is rooted in universal human nature. The only limitation to the I-Change model is an individual’s 
willingness and determination to change. Because an individual’s awareness or motivation is 
variable, some individuals may stall in a particular stage without progressing to the next stage in 
the I-Change Model.  
Gaps 
 The I-Change model is versatile in its usage and easy to implement in most settings, 
including healthcare environments such as inpatient settings, outpatient clinics, community based 
settings, or home healthcare visits. The model is viable when used in a large hospital as well as 
in a free clinic that provides care to working class people without insurance. Since the I-Change 
model is simple, straightforward and easy-to-comprehend, it can be used in any facility, any city, 
and any country in the world with high success. Although the I-Change model has been used in a 
variety of settings, it use has not been publicized in African Americans or rural settings.  
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The quality and amount of healthcare that minority Americans receive is less than the 
recommendations. Minorities are less likely to receive preventative healthcare, are more likely to 
develop conditions such as heart disease or diabetes, and are less likely to have a healthcare 
provider who is familiar with their situation and whom they visit on a regular basis for check-ups 
(Graham, 2011). These minority individuals are less likely to receive health-screenings or to 
have easily available and affordable healthcare. Among African-Americans, for example, close 
to half of the population has hypertension (CDC, 2012). A large number of African Americans 
do not have access to regular healthcare and, therefore, may believe that medicine or visits to a 
healthcare provider are unimportant until severe complications develop (Artinian, Washington, 
& Templin, 2001). Educating African Americans about the risks of high blood pressure and 
teaching them how to monitor their blood pressure at home will result in more people realizing 
that high blood pressure is a serious, important health factor that should not be overlooked. 
According to the I-Change Model, being aware of a risky behavior could move an individual 
toward motivation to attend to the serious condition of hypertension. This motivation could make 
more patients attempt to adhere to their blood pressure medication regimen as a behavior change. 
The I-Change Model is a framework that could influence African Americans to take greater care 
to lower their blood pressure. Using the I-Change model would be easy and efficient and have a 
positive impact on the health and well-being of African-Americans and other minority groups. 
The Integrated Theory of Health Behavior Change suggests that health behavior change can be 
enhanced by fostering knowledge and beliefs, increasing self-regulation skills and abilities, and 
enhancing motivation. 
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Application 
In the case of implementing the I-Change model to treat hypertension among African-
American patients, there are no modifications that need to be made in the basic model. The 
intervention is done in three parts: awareness, motivation and behavior. In the awareness step of 
this project, the patients would receive instruction on the health risks of untreated hypertension 
and the potential complications. The patients would also be taught how to easily monitor his/her 
blood pressure at home. By performing home blood pressure monitoring, an individual would 
have an increased awareness by increasing his/her risk perception with visual cues to trigger a 
need for behavior change. The motivation step of the project would involve the individual 
applying the new knowledge, performing home blood pressure monitoring, and keeping a record 
of his/her blood pressure results. Seeing his/her blood pressure results and knowing the potential 
outcome of leaving high blood pressure untreated are cues about the individual’s risk. Hopefully, 
this knowledge would lead the individual to transition to the third stage of the I-Change model’s 
process, which is behavior.  It is in this final step that the patient applies his/her motivation and is 
spurred into action for behavior change. The individual engages actively to do his/her best to 
lower his/her blood pressure by adhering to the prescribed medical regimen. The determination 
to change their behavior is built on the model’s components of awareness and motivation. The 
intervention will have run its course when the patient engages in behavior that is compliant with 
his/her prescribed medical regimen. 
 The biggest barrier to achieving the desired behavior is the chance that the patient 
becomes stalled at one stage of the process before the behavior change occurs. This stall risk is 
most likely to occur in the beginning of the process, when the patient may not have enough 
interest or social support to move on to the second stage. In the motivational stage, the patient 
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might experience waning motivation, which could delay progress to the final behavior change. If 
a person is not ready to change, then the change will not occur. People develop motivation and 
readiness at different rates; some will need time before they are ready to actively make a change 
in their behavior.  
 Healthcare providers need to be aware that the I-Change model is a three-stage process. 
A patient must proceed from one stage to the next in a predetermined order before s/he can 
succeed in changed behavior. Motivation cannot come before awareness, since it is difficult to 
become motivated to change something if one is not aware it is an issue. It must be noted that the 
patient is likely to move back and forth between the stages based on his/her emotional outlook at 
any given point in time. The patient’s determination and desire to make a change are of great 
importance in achieving success. Therefore, it is entirely likely that a patient may move between 
stage one and two or two and three several times before a permanent behavior change takes 
place. Healthcare providers should recognize this movement between stages as commonplace.  
Conclusion 
 Though non-adherence to hypertension treatment is a serious problem with African-
American patients, the I-Change model of intervention would be an efficient model to help 
patients to comply with their prescribed medical regimen. Through education about their 
condition, potential complications that could arise due to non-compliance with prescribed 
treatments, and information on how to monitor their blood pressure at home, the patient will be 
motivated to make a behavior change. Because the I-Change model is effective, simple to follow, 
and adaptable to any environment, it  is an ideal model choice in behavior modification. The I-
Change model can help many patients change their health behavior. Implementing this model 
would create a positive change in African Americans with hypertension in a rural setting.  
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Engagement in healthy behavior is essential to improvement of health and management 
of chronic conditions. Nurses and other healthcare providers benefit from knowing how to 
support the initiation and maintenance of health behavior change by individuals. The I-Change 
model presented is an integration of past successes and makes substantive contributions to 
understanding health behavior change by combining knowledge and beliefs, and self-regulation 
processes. It is purported that the behavior changes necessary to manage chronic conditions are 
more similar than different than behavior changes necessary for health promotion. Measurement 
of behavior change occurs proximally to ensure that behavior change has actually occurred, as 
well as distally to ensure attainment of improved health status. 
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High blood pressure is a major risk factor for heart disease and stroke, both of which are 
leading causes of death in the United States. Nearly one-third of all American adults have high 
blood pressure and more than half of those affected do not have well-controlled hypertension 
(Center for Disease Control [CDC], 2013). Hypertension is 30%–50% more prevalent in African 
Americans than Caucasians and accounts for half of the excess cardiovascular mortality observed 
in African Americans (Bravermen & Dieder, 2009). Of those diagnosed with hypertension, 
African Americans have lower rates of blood pressure (BP) control than other ethnicities, and 
this disparity has increased over time (Bravermen & Dieder, 2009). Poor medication adherence 
to prescribed antihypertensive medications contributes significantly to lower BP control and 
increasing such adherence is considered to have the greatest potential to improve BP control 
(CDC, 2013). According to a 2003 report by the World Health Organization, approximately 50% 
of patients do not adhere to their medications as prescribed (Brown & Bussell, 2011). Adherence 
is a key factor associated with the effectiveness of all pharmacological therapies but is 
particularly critical for medications prescribed for chronic conditions. Of all medication-related 
hospitalizations that occur in the United States, between one-third and two-thirds of the 
admissions are the result of poor medication adherence (CDC, 2013). Home blood pressure 
monitoring is one strategy that can be implemented in the African American community to 
improve medication adherence in an effort to reduce morbidity and mortality related to 
hypertension.  Home blood pressure monitoring  is defined as the regular measurement of blood 
pressure by the patient outside the clinical setting, either at home or elsewhere (Bravermen & 
Dieder, 2009). The purpose of this project, is to evaluate the effectiveness of home blood 
pressure monitoring on medication adherence and blood pressure control in African Americans. 
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Theoretical Framework 
The theoretical framework for this project is based on the I-Change model. The I-Change 
model is loosely founded on the Attitude-Social Influence-Self efficacy (ASE) model 
(Broekhuizen, van Poppel, Koppes, Brug & Mechelen, 2010). The I-Change model consists of 
three components; Awareness, Motivation, and Action. In the initial Awareness step, the patient 
is made aware not only of the risk of unmanaged hypertension [HTN], but also of the need for 
changing his/her behavior.  In this scholarly project, the initial step was accomplished by sharing 
information with the patient about the risks involved in ignoring their hypertension, as well as 
the benefits of improved HTN control.  Because patients recall as little as 50% of what is 
discussed during the typical medical encounter, effective patient education must be 
multifactorial, and individualized (Brown & Bussell, 2011). A key component of any adherence-
improving plan is patient education. This knowledge could provide awareness for his/her need of 
a change. Following the Awareness step of the I-Change model is Motivation. In the Motivation 
step, an individual became motivated to improve his/her health habits. In this scholarly project, 
Motivation was accomplished through teaching the patients to self-monitor their blood pressure 
at home.  When an individual saw the actual blood pressure numbers and related the BP values to 
information related to HTN risks, she/he was motivated to change their current habits in order to 
reduce risks and improve benefits. Proceeding through the motivational step of the I-Change 
model resulted in the patient developing positive intentions to change his/her current behavior. 
The final step of the I-Change process after Awareness and Motivation is the Action step. In the 
Action step of the scholarly project, the patient followed the natural course of Awareness and 
Motivation and took Action to improve his/her medication adherence to reduce risk and improve 
benefit of managed HTN. In this project, the patient took action by following his/her prescribed 
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medication regimen.  In order to create Motivation, individuals were taught how to use a home 
blood pressure monitor.  The individual was motivated by seeing and recording his/her daily 
blood pressure values.  Seeing his/her blood pressure values combined with Awareness of the 
risks of uncontrolled HTN and the benefits of managed HTN, facilitated the individual Action of 
taking antihypertensive medications as prescribed.  
Design 
 This project was a feasibility pilot study, which used a randomized control design. 
Participants were randomly assigned to one of two groups. Group A, received the intervention of 
home-monitoring plus education, and Group B, received usual care (clinic monitoring).  
Randomization assignments were determined before the start of data collection by using an 
online randomization tool. Approval by the Belmont University Institutional Review Board was 
obtained prior to implementation of the study. 
Setting/Sample 
 This scholarly project was conducted in Tunica County Mississippi at the Preventative 
Health Clinic, one of two clinics serving the area. Preventive Health Clinic provides health 
services to more than 1000 adults and children, 90% of whom are African American.  
Approximately 50% of the clinic’s patients have HTN and are prescribed medications to control 
and manage the chronic disease.  The majority of Tunica County residents are African American 
(76%) and many are below the poverty level according to the most recent US Census 
information (2013).  The Tunica County residents reflect the state of health in Mississippi in 
which not only more than 700,000 adults have HTN, but also in which cardiovascular disease is 
the highest in the nation.   
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Recruitment 
Recruitment for potential participants was conducted between June 1, 2013 and 
September 30, 2013. Recruitment posters were posted throughout Tunica County at businesses   
(Exxon gas station, Piggly Wiggly grocery store, and the Fred’s convenience store), flyers were 
placed in church bulletins (the Macedonia, St. Luke, Belmont, and Love Temple Baptist 
churches) and advertisements were published in the local newspaper (Tunica Times). Inclusion 
criteria for participants were: 1)African American patients diagnosed with hypertension and 
prescribed anti-hypertensive medication, 2) >18 years of age, 3)English speaking, and 4)non-
adherent to their medications as evidenced by self- report and by the Morisky 8-Item Medication 
Adherence Questionnaire. Exclusion criteria: 1) physical, mental and health restrictions, 2) 
unable to duplicate self-monitoring demonstration, 3) less than 18 years of age, and 4) 
participants not meeting inclusion criteria. Participants were asked to contact the investigator via 
telephone or email if interested in participating in the study. 
 During the recruitment phase, potential participants contacted the principal investigator 
(PI) via email or phone if he/she was interested in the study. During the initial phone call, a 
mutually agreeable upon date and time was set to meet with the participant at Preventative Care 
Health Services clinic. The potential participant completed the Morisky 8-Item Medication 
Adherence Questionnaire and a demographic survey. If the participant scored greater than a 2 on 
the Morisky Questionnaire, and met all other inclusion criteria, this person was eligible to 
participate in this project.  After determining eligibility, the principal investigator obtained an 
informed consent and baseline blood pressure readings. 
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Data Collection 
Eligible participants were randomized into two groups; the home blood pressure 
monitoring group (intervention group n=10) or the usual care group (clinic monitoring n=10). An 
online randomization tool was utilized to determine group orientation. At the first meeting, 
participants in the intervention group were given a brief overview of hypertension, which 
included: signs and symptoms, the staging of hypertension based on the JNC-VII guidelines, and 
the meaning of systolic and diastolic blood pressure values. All provided education materials 
were located in the manufacture’s home BP monitor instruction manual.  After the education 
session was completed, the principal investigator measured the participant’s arm and selected the 
appropriate blood pressure cuff. The participants were instructed on the  proper technique of 
taking an accurate blood pressure and given an education pamphlet to reinforce learning (See 
Appendix A). To validate understanding, each participant performed a return demonstration. The 
blood pressure machine used for this project was the Omron 7 series model BP760. To ensure 
reliability, the machine was validated and approved by the Association for the Advancement of 
Medical Instrumentation, the British Hypertension Society and the International Protocol for the 
Validation of Automated BP Measuring Devices. The principal investigator calibrated the blood 
pressure machine. The participants were asked to take his/her blood pressure twice a day, one 
reading in the morning and one in the evening for 12 weeks, and record his/her readings in the 
provided journals. The usual care group had their blood pressure taken during the study time 
according to the recommendations of his/her PCP. At the end of the 12-week period, the usual 
care and the intervention group participants returned to the clinic to complete the post-
intervention Morisky questionnaire, and have their blood pressure taken and recorded by the 
principal investigator. The primary project objective was to demonstrate increased medication 
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adherence after 12 weeks of home self-monitoring blood pressure with a decreased Morisky 
score. The secondary project objective was to have an improvement in blood pressure values as 
evidenced by a drop in systolic and diastolic blood pressure values after 12 weeks.  
Data Analysis 
Data analysis procedures were conducted by using SPSS statistical software. Descriptive 
statistics were used to analyze all study variables. Fisher’s exact was used to measure medication 
adherence and blood pressure control between groups. Blood pressure was analyzed as the 
dichotomous variable (“uncontrolled” or “controlled”) according to the JNC-VII national 
guidelines (Chobanian, Bakris, Black, Cushman, Green, Izzo, et. al., 2008). Specifically, among 
non-diabetic participants systolic blood pressure (SBP) values ≥140 mmHg and diastolic blood 
pressure (DBP) values ≥90 mmHg were considered “high”. The corresponding BP cut-off for 
diabetic participants was 130/80 mmHg. 
Self-reported medication adherence was measured with the eight-item Morisky 
Medication Adherence Scale (MMAS) (Morisky, Krousel-Wood, & Ward, 2008). This 
adherence measure was designed to facilitate the identification of barriers to and behaviors 
associated with adequate adherence to chronic medications. In previous studies, the scale has 
been reliable (α= 0.83) and associated with significant blood pressure control (p<0.05) in low 
income, mostly minority and underserved individuals with hypertension. Also, the MMAS has 
demonstrated high concordance with antihypertensive medication pharmacy fill rates. MMAS 
scores range from 0 to 8 with low adherence defined as >2; medium adherence as 1 to 2, and 
high adherence as 0 (Morisky, Krousel-Wood, & Ward, 2008). For this scholarly project, the 
MMAS score was summed and dichotomized into 2 categories. Non- adherence was any score 
greater than two, and adherence was any score less than or equal to two.  (see Appendix B).  
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Results 
Of 20 patients included in the study, 45% were between the ages of 31-40, 60% were 
women, 40% had graduated from high school, and the mean number of antihypertensive 
medications being taken was 1.5 (range, 1-4 medications).  Complete demographic 
characteristics of the study participants are listed in Table 1.  The mean (SD) MMAS score was 
7.4 (0.9).  A chi-square 2x2 was performed to find a significant difference between those in the 
intervention group and increased medication adherence. However, since the predicted cell size 
for two of the cells was 4, the chi-square test was not appropriate to calculate the p value. 
Because the predicted cell size was less than 5, the Fisher’s exact test was appropriate to 
calculate the p-value (See Table 5). The Fisher’s exact test found a significant difference for 
medication adherence between the home monitoring group and the usual care group, p<.05. 
Seventy percent of patients in the home monitoring group had an improved medication 
adherence score compared to only 10% in the control group post intervention. After blood 
pressure was dichotomized, a chi-square test was used to determine whether there was a 
significant difference in blood pressure control between participants who performed home blood 
pressure monitoring and those who did not. There was not a significant difference found between 
the intervention group and control group with p >.05.  
Discussion 
 The purpose of this project was to test the effectiveness of home blood pressure 
monitoring on medication adherence and blood pressure control in African Americans with 
HTN. Despite the small sample size, results indicate that the participants in the intervention 
group had a statistically significant difference in their medication adherence scores after the 
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intervention than those in the control group. Although there was a lower reduction in both 
systolic and diastolic blood pressures in the intervention group compared to the control group, 
these results were not statistically significant (figure 1 & 2). Participants in both groups had 
blood pressures values that were normal post intervention. This result may have been related to 
the participants in the control group using other methods for improving BP such has exercise or 
other lifestyle modifications. Of the twenty participants, only three had an uncontrolled blood 
pressure post intervention, two were in the control group and one in the intervention group. This 
result may have been related to the anxiety of being in the study. 
.  These are important pilot results, which, if replicated in a larger sample, could 
significantly improve care and health outcomes for African Americans with hypertension in a 
rural setting. Home blood pressure monitoring allows the patient to gain an increased interest in 
the management of their hypertension and to provide the patient with self-confidence and 
feelings of reassurance. The tangible blood pressure readings from home blood pressure 
monitors turned this largely asymptomatic disease into a condition that is measurable in the 
patients' own homes. Seeing and recording the blood pressure readings could be the patient’s 
motivation facilitating the Action of adhering to his/her prescribed medication regimen. 
Although there may be advantages to home BP monitoring, more research is needed to determine 
the effects of this strategy on long-term control of hypertension. 
Limitations 
Some of the limitations of this study include external validity, or the generalizability of 
the study. There were only 20 participants who participated in the complete study, and all but 
one of the participants were high school graduate or beyond. In addition, the participants were all 
middle to upper middle class adults. In future studies, more research is needed to view 
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medication adherence in individuals with low socioeconomic status. Tunica, MS is a small rural 
community and the principal investigator is well known.  Many of the participants knew the PI, 
and this could have caused a false positive result related to the participants wanting to perform 
well because they knew the principal investigator. In this project, the PI purchased individual 
blood pressure cuffs. Some individuals that are at or below poverty level may not have the 
additional funds to purchase a personal blood pressure monitor therefore, future studies are 
needed on the effectiveness of public kiosk monitoring on medication adherence and blood 
pressure control. There was a small amount of education performed at the beginning of the 
project based on information from the pamphlet in the blood pressure machine. This may have 
not been enough information to create awareness to promote a true behavior change that could be 
sustained. In future studies, additional educational information is needed in the form of a video 
or handouts to ensure that the participants understand the information. In addition to this added 
education, more qualitative information is needed on the participants feelings and their response 
to home blood pressure monitoring and medication adherence.  
Implication for Nurses 
Nurses play a pivotal role in helping patients to adhere to their medication and increasing 
blood pressure control. Nursing leadership is important in helping the community understand the 
importance of taking control of their health. One strategy is through self blood pressure 
monitoring. For this study, blood pressure monitors were purchased for the participants use, but 
consideration must be given to individuals who can not afford to purchase a home blood pressure 
monitor. Self- service kiosks are designed to help consumers monitor and improve their actual 
health. These health-related kiosks allow users to conveniently monitor their condition, set 
personal health goals, and measure and track their results. In most cities throughout the United 
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States, kiosks are usually located at the local grocery stores or pharmacy and can be used at the 
customer’s convenience. In the small town of Tunica, MS., there are currently no blood pressure 
kiosks located in any of the grocery stores or pharmacies. Since Tunica has only two health 
clinics that service about 8,000-10,000 people, scheduling an appointment is often difficult.  
Although the prices of the blood pressure kiosks are expensive, research has shown that 
the long-term benefits of a public kiosk are beneficial. Atkins (1996) found that public kiosks 
had a profound effect on pharmacy revenue. Stores that had a blood pressure kiosk increased 
pharmacy revenue by more than fifty percent. Atkins (1996) also found that grocery stores with a 
kiosk had increased sales and revenue. Research shows that consumers enjoy the convenience of 
self‐service and are more likely to do business with companies that offer the convenient service. 
A cost- effective study performed by the principal investigator examined the cost of clinic 
monitoring versus kiosk monitoring and found that the total cost would be $16.44/person at the 
clinic and $.40/person at the kiosk (See figure 3).  
It was important to advocate and share with key stakeholders the importance of 
purchasing a blood pressure kiosk for the people of Tunica, MS.  The PI had a meeting 
scheduled with Rev. McKinnely Daley, a representative on the Tunica County Board of 
Supervisors to discuss obtaining a public blood pressure kiosk for the residents of Tunica, MS. 
Before the scheduled meeting, a vandalism event occurred at the local high school incurring 
more than one hundred thousand dollars in damages.  In Tunica County, this was not only a 
significant expenditure, but also a major disruption in the community. Therefore, the meeting 
between the PI and the County Supervisor was postponed, and is currently pending. Nurses 
should seek opportunities to advocate for the patient and the community. Advocacy and 
MEDICATION ADHERENCE   64 
 
leadership are appropriate roles for nurses that can positively impact individuals’ and 
communities’ health.  Nurses can assess communities’ needs and find cost effective solutions 
similar to the described home blood pressure monitoring project.  
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TABLE 1  
Characteristics of Participants 
(n=20) 
 
Characteristics  N(%) 
Age   
 31-40 9(45) 
 41-50 6(30) 
 Over 51 5(25) 
Gender   
 Female 12(60) 
 Male 8(40) 
Education   
 Completed HS 8(40) 
 Some College 4(20) 
 College 7(35) 
 Graduate 1(5) 
Employment   
 Fulltime 18(90) 
 Part-time 1(5) 
 Unemployed 1(5) 
Income   
 <$200/week 1(5) 
 $200-$499/week 6(30) 
 $500-$799/week 7(35) 
 $800-$1000/week 5(25) 
 >$1000/week 1(5) 
 
 
 
 
Table 2: Hypertension Characteristics 
 Mean (S.D.) Range 
Number of Meds 1.5 (.76) 1-4 
Years with HTN 2.4(.99) 1-4 
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Table 3:  Pre/Post BP Values 
 
 Mean (S.D.) Range 
Systolic BP   
Pre-intervention 139.35 (17.30) 122-200 
Post-intervention 134.25 (10.77) 118-160 
   
Diastolic BP   
            Pre-intervention 83.95(15.05) 62-125 
            Post-intervention 76.20(6.70) 68-88 
 
 
Table 4: Pre/Post Morisky scores 
 
 
 Mean (S.D.) Range 
Morisky Score   
             Pre-intervention 5.45 (1.31) 3-7 
             Post-intervention 3.95(1.87) 1-7 
 
 
Table 5:  Chi-Square Test and Fisher’s Exact 
 
 
Chi-Square Tests 
 Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-
Square 
7.500
a
 1 .006   
Continuity 
Correction
b
 
5.208 1 .022   
Likelihood Ratio 8.202 1 .004   
Fisher's Exact 
Test 
   .020 .010 
Linear-by-Linear 
Association 
7.125 1 .008   
N of Valid Cases 20     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 
4.00. 
b. Computed only for a 2x2 table 
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Appendix A: Educational Handout 
 
The ABCD’s of Blood Pressure Measurement  
 
Achieve a calm state 
 Make sure you are quiet and relaxed 
   Sit calmly without talking for about 5 minutes  
 Make sure your reading isn’t affected by:   caffeine, alcohol,  
exercise  
or smoking 
Body posture is important 
 Sit in a chair with feet on the floor  
 Legs should not be crossed  
 Arm should be bare and should be supported at heart level  
Calibrate & check equipment  
 Use a properly calibrated and validated instrument  
 Check the cuff size and fit  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Double check any high readings  
 If blood pressure registers high,take two readings 5 minutes 
 apart 
 Confirm any elevated readings in the opposite arm  
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Appendix B:  Morisky 8-item Medication Adherence Questionnaire 
 
 
 
Morisky 8-Item Medication Adherence Questionnaire 
Question 
Patient Answer 
(Yes/No) 
Score Y=1; N=0 
Do you sometimes forget to take your medicine? 
  
People sometimes miss taking their medicines for reasons other than forgetting. Thinking over the past 2 weeks, were there 
any days when you did not take your medicine?   
Have you ever cut back or stopped taking your medicine without telling your doctor because you felt worse when you took 
it?   
When you travel or leave home, do you sometimes forget to bring along your medicine? 
  
Did you take all your medicines yesterday? 
  
When you feel like your symptoms are under control, do you sometimes stop taking your medicine? 
  
Taking medicine every day is a real inconvenience for some people. Do you ever feel hassled about sticking to your 
treatment plan?   
How often do you have difficulty remembering to take all your medicine? 
__ A. Never/rarely  __ B. Once in a while __ C. Sometimes  __ D. Usually  __ E. All the time  
A = 0; B-E = 1 
 
Total score 
 
Scores: >2 = low adherence 1 or 2 = medium adherence 0 = high adherence 
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74. 
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Figure 1- Pre and Post Intervention Systolic Blood pressure 
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Figure 2- Pre and Post Intervention Diastolic Blood Pressures 
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Figure 3 
 
 
 
 
  
Clinic Monitoring 
  
Blood pressure machine 
.40 
Transportation to clinic 
$11.00 
completing paper work ($3.36 adm. fee) 
nurse performing bloodpressure 
($1.68 nurse wage) 
Results  
Total Cost $16.44 
Ambulatory Blood pressure 
Monitoring ( kiosk) 
Kiosk blood pressure 
0.40 
transportation to kiosk (at patient's 
convience  
0.00 
no wait time (0.00)  
no nurse wage  
0.00 
Instant REsults 
Total Cost 0.40 
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Scholarly Project Conclusion 
 
Hypertension in the African American population is a substantial problem that continues 
to grow. Medication adherence is one effective method to controlling blood pressure in African 
Americans. As discovered through the literature search, there have not been enough studies 
evaluating improving medication adherence and blood pressure control in a rural setting. As a 
result, there is minimal understanding of the population and its healthcare and other needs. It 
must be emphasized that accurate measurement of blood pressure is of fundamental importance 
in management of hypertension.  Through this scholarly project, it was found that home blood 
pressure monitoring led to an increase in medication adherence. Although there was not 
significance in actual blood pressure control, this pilot study shows the need for further research 
in this population.  
The writing and research of this project gave me the opportunity to expand ways to help 
the people of my community. The continuation of research in this area is critical in finding cost 
effective ways to manage this asymptomatic disease. As a healthcare provider, it is important to 
bridge the gap between the availability of effective interventions and successful control of 
hypertension. 
 
 
